Showing 8781-8790 of 19239 results for "".
- Open‑Platform Robotic Knee Replacement Hits High Mark for Accuracy Across Multiple Implantshttps://reachmd.com/news/emerging-surgical-devices-and-algorithms-that-change-operative-decisions-and-safety-for-athletes/2483876/A new multicenter study suggests that open-platform robotic systems can achieve high alignment accuracy in total knee arthroplasty (TKA) across a range of implant types, potentially offering s
- Emerging Insights into HTLV-1 Persistence and Therapeutic Advanceshttps://reachmd.com/news/emerging-insights-into-htlv-1-persistence-and-therapeutic-advances/2476004/Human T-cell leukemia virus type 1 (HTLV-1) persistence hinges on its capacity to enter latency, evading immune detection and complicating efforts to eradicate infected cells. Recent discoveries reveal a
- Innovative Treatments in COPD and IPF: A New Era of Personalized Managementhttps://reachmd.com/news/innovative-treatments-in-copd-and-ipf-a-new-era-of-personalized-management/2475850/Emerging evidence from pooled phase 3 BOREAS and NOTUS trials reveals that dupilumab improves lung function in COPD patients with heightened type 2 inflammation, indicating a
- Emerging Frontiers in Cancer Immunotherapy: CAR-T Cells and Innovative Techniqueshttps://reachmd.com/news/emerging-frontiers-in-cancer-immunotherapy-car-t-cells-and-innovative-techniques/2475009/In the evolving landscape of oncological care, CAR-T cell innovation is transforming personalized therapy for hematologic malignancies while emerging adjuncts promise to amplify systemic immune responses across diverse tumor types. Whi
- Atrasentan Reduces Proteinuria in IgA Nephropathy Patients in New Trial Findingshttps://reachmd.com/news/atrasentan-reduces-proteinuria-in-iga-nephropathy-patients-in-new-trial-findings/2468546/A study published in the New England Journal of Medicine and presented at the American Society of Nephrology’s Kidney Week indicates that atrasentan, a selective endothelin type A receptor antagonist, significantly reduces proteinuria in patients with immunoglobulin A (IgA) nephropathy.
- A Deep Dive on Inflammatory Pain Could Open Up New Solutionshttps://reachmd.com/news/a-deep-dive-on-inflammatory-pain-could-open-up-new-solutions/2467055/A new study reveals thousands of molecular interactions between pain-sensing neurons and different types of immune cells. (Images: Adobe Stock | Illustration: Sebastian Stankiewicz, Boston Children’s Hospital)
- Cancer Immunotherapy Used to Treat Asthmahttps://reachmd.com/news/cancer-immunotherapy-used-to-treat-asthma/2466980/Chimeric antigen receptor (CAR) T cells are a form of immunotherapy in which T cells, a type of immune cell, is engineered to recognize and target the tumor. T cells are responsible for killing or lysing infections in a healthy immune system. Unfortu
- Scientists Identify Highly Infectious, Antibiotic-Resistant E. coli Strain in Chinahttps://reachmd.com/news/scientists-identify-highly-infectious-antibiotic-resistant-e-coli-strain-in-china/2457039/A new type of E. coli that is both highly infectious and resistant to some antibiotics has been discovered. The newly identified mutation of antibiotic-resistant E. coli is described in a new paper in Nature Communi
- City of Hope Research Reveals an Immune Cell That Can Attack Cancerhttps://reachmd.com/news/city-of-hope-research-reveals-an-immune-cell-that-can-attack-cancer/2456837/According to preclinical research published online today in Cell, one of the world’s premier scientific journals, researchers at City of Hope® have discovered that a type of immune cell in the human bo
- Overcoming Tumor Recurrence: Advancements in Cancer Immunotherapyhttps://reachmd.com/news/overcoming-tumor-recurrence-advancements-in-cancer-immunotherapy/2475268/Persistent tumor recurrence is a significant challenge in oncology, with recurrence rates varying by cancer type. These